The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 09, 2025

Filed:

Nov. 14, 2022
Applicant:

Benevolentai Technology Limited, London, GB;

Inventors:
Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G16H 50/70 (2018.01); G16B 15/30 (2019.01); G16B 40/20 (2019.01); G16H 70/40 (2018.01);
U.S. Cl.
CPC ...
G16H 50/70 (2018.01); G16B 15/30 (2019.02); G16B 40/20 (2019.02); G16H 70/40 (2018.01);
Abstract

A computer-implemented method of training a machine learning model to identify biological entities for drug discovery is disclosed. The method comprises providing a training data set comprising a plurality of entity-linked text sequences, each text sequence including a mention of a biological entity, where the biological entity is linked to a corresponding biological entity identifier from a set of possible biological entity identifiers; masking the mention of the biological entity within each text sequence; encoding each masked text sequence into an input representation for a machine learning model; and training a machine learning model to predict the unique entity identifier of the masked biological entity based on the input representation. The described method is able to utilise the full breadth of the rich contextual information available in the biomedical text corpus to predict new biological targets for drug discovery and avoids the restrictions intrinsic to relationship prediction using knowledge graphs. The ability to identify more promising, biologically relevant targets in an automated manner, significantly reduces the requirement of human input and reduces the failure rate in targets that are progressed in the drug delivery pipeline.


Find Patent Forward Citations

Loading…